WASHINGTON: Pfizer and BioNTech said their vaccine is around 91% effective at preventing COVID-19, citing updated trial data that included participants inoculated for up to six months. The shot also showed early signs of preventing disease in a small subset
BERLIN: German company BioNTech, which developed the first coronavirus vaccine approved in the West, said it expects to produce two billion doses in 2021, up from the 1.3 billion previously forecast. “We now believe that we can potentially deliver approximately
GENEVA: The World Health Organization granted emergency validation to the Pfizer-BioNTech vaccine, paving the way for countries worldwide to quickly approve its import and distribution. Britain launched its inoculation drive with the US-German vaccine on December 8, followed by the
WASHINGTON: The United States has purchased an additional 100 million doses of the Pfizer/BioNTech vaccine against COVID-19, with the shots set to be delivered by July, the Pentagon announced. That brings the current US supply of Covid-19 vaccine to 400
BRUSSELS: The European Union finally gave the green light for the Pfizer-BioNTech coronavirus vaccine, paving the way for the first inoculations to start across 27 countries just days after Christmas. The decision was rushed through under pressure from European governments
BASELL: Switzerland has approved the use of the Pfizer-BioNTech vaccine, with immunisation set to start just after Christmas as the country battles rising coronavirus cases. The Swissmedic regulatory authority said it had given the green light following a two-month review.
WASHINGTON: The United States has approved the Pfizer-BioNTech Covid-19 vaccine, paving the way for its imminent rollout across the country, President Donald Trump promising the first immunizations would take place “in less than 24 hours.” “I am authorizing the emergency